Genetic Association Estimate for Lipoprotein(a)-Lowering Therapies
A mendelian randomization analysis revealed that Lipoprotein(a) [ Lp(a)]concentration must be lowered by approximately 100 mg/dL to achieve the same reduction in coronary heart disease (CHD) risk as can be achieved by lowering low-density lipoprotein cholesterol (LDL-C) level by 38.67 mg/dL. The analysis involved more than 80 000 patients and more […]